Sponsor Dossier
SciGen
Sponsor Dossier for SciGen. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: SCITROPIN A
- Brand: ZOMETA
- Device (sponsor): Cartridge-accepting autoinjector, mechanical
About
SciGen is an Australian Private Company with ABN 76 055 016 969, registered in New South Wales and currently active.
Portfolio
SciGen's ARTG portfolio comprises 2 brands, of which 2 are indexable. Both brands have Product Information on file. One brand is PBS-listed and both brands have PBAC outcomes on record. Notable brands include SCITROPIN A and ZOMETA.
Therapeutic focus
— Oncology: 1 brand — Endocrinology: 1 brand
PBS footprint
SciGen has 1 brand with at least one PBS-listed item, with the latest PBS schedule date their portfolio touched being 1 May 2026.
Regulatory activity
SciGen's latest PBAC outcome was dated 1 September 2023, with 2 brands holding PBAC outcomes on record.